Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85166283 | 8516628 | 3 | F | 20160602 | 20120417 | 20160816 | PER | US-ASTRAZENECA-2011SE70260 | ASTRAZENECA | 74.00 | YR | M | Y | 95.30000 | KG | 20160816 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85166283 | 8516628 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 21153 | ||||||||||
| 85166283 | 8516628 | 2 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | U | 0 | MODIFIED-RELEASE TABLET | |||||||||
| 85166283 | 8516628 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | TABLET | QD |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 85166283 | 8516628 | Adverse event | |
| 85166283 | 8516628 | Diabetes mellitus | |
| 85166283 | 8516628 | Drug dose omission | |
| 85166283 | 8516628 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 85166283 | 8516628 | 3 | 2010 | 0 |